{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T20:47:29Z","timestamp":1771879649393,"version":"3.50.1"},"reference-count":21,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2005,7,29]],"date-time":"2005-07-29T00:00:00Z","timestamp":1122595200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2005,8]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background:\u2002<\/jats:bold> On\u2010demand therapy with esomeprazole is effective for long\u2010term treatment of non\u2010erosive gastro\u2010oesophageal reflux disease, but it has not been evaluated in erosive gastro\u2010oesophageal reflux disease.<\/jats:p><jats:p><jats:bold>Aims:\u2002<\/jats:bold> To compare endoscopic and symptomatic remission over a 6\u2010month period when patients with healed erosive gastro\u2010oesophageal reflux disease are treated with esomeprazole 20\u2003mg, either once daily or on\u2010demand.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> Patients with verified erosive reflux oesophagitis of Los Angeles grades A\u2013D were enrolled. Following 4\u20138\u2003weeks treatment with esomeprazole 40\u2003mg daily, those who were endoscopically healed and had symptom control during the last week were randomized to maintenance therapy for 6\u2003months with esomeprazole 20\u2003mg, taken either once daily or on\u2010demand.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> Of 539 enrolled patients, 494 (91%) were healed at 8\u2003weeks and 477 were randomized to maintenance therapy with esomeprazole 20\u2003mg, 243 once daily and 234 on\u2010demand. After once daily treatment, 81% of patients were still in remission at 6\u2003months, compared with only 58% who took on\u2010demand treatment (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.0001). A difference in remission was found irrespective of baseline grade of oesophagitis, but it was more pronounced for the more severe grades. There was no difference in overall symptomatic remission between the two treatments, although heartburn was significantly more prevalent in the on\u2010demand group.<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold> Once daily esomeprazole 20\u2003mg was better than that taken on\u2010demand for maintaining healed erosive oesophagitis, regardless of baseline Los Angeles grade.<\/jats:p>","DOI":"10.1111\/j.1365-2036.2005.02553.x","type":"journal-article","created":{"date-parts":[[2005,7,29]],"date-time":"2005-07-29T18:12:17Z","timestamp":1122660737000},"page":"183-191","source":"Crossref","is-referenced-by-count":72,"title":["Daily treatment with esomeprazole is superior to that taken on\u2010demand for maintenance of healed erosive oesophagitis"],"prefix":"10.1111","volume":"22","author":[{"given":"S.","family":"SJ\u00d6STEDT","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"BEFRITS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"SYLVAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"HARTHON","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"J\u00d6RGENSEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"CARLING","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"MODIN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"STUBBER\u00d6D","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"TOTH","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"LIND","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,7,29]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1159\/000200911"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529709011212"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.45.2.172"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.44.2008.S1"},{"key":"e_1_2_6_6_2","first-page":"1103","article-title":"On demand therapy with omeprazole for the long\u2010term management of patients with heartburn without oesophagitis placebo\u2010controlled randomized trial","volume":"14","author":"Lind T","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9270(03)00014-5"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2001.00943.x"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365520212499"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2001.01024.x"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1997.00167.x"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0953-0673.2004.01828.x"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.01916.x"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200220040-00005"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2003.10.012"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199903183401101"},{"key":"e_1_2_6_17_2","first-page":"37","article-title":"Natural course of gastroesophageal reflux disease: 17\u201322\u2003year follow\u2010up of 60 patients","volume":"92","author":"Isolauri J","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.05912.x"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.028076"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2004.042143"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529709011211"},{"key":"e_1_2_6_22_2","first-page":"2591","article-title":"Correlation between patient demographics and heartburn severity with Los Angeles (LA) classification of erosive esophagitis","volume":"94","author":"Levine D","year":"1999","journal-title":"Am J Gastroenterol"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2005.02553.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2005.02553.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T22:08:33Z","timestamp":1697234913000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2005.02553.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7,29]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["10.1111\/j.1365-2036.2005.02553.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2005.02553.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,7,29]]}}}